Reports

Drug name	NICE TAs	Comments
Oxycodone hydrochloride capsules		Lynlor capsules preferred brand
Oxycodone hydrochloride M/R tablets		Reltebon MR tablets preferred brand
Oxygen		Short term use in palliative care
Oxygen#3.6		Long term use - requires specialist assessment
Paclitaxel injection	TA214 - Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancer TA284 - Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer	Negative TA
Palifermin injection		Private patients only
Paliperidone (Byannli®)		6 monthly injection
Paliperidone (Trevicta®)		Third line option Patient has been stable mentally for at least 12 months and had a stable dose of paliperidone palmitate monthly injection and has not required a dosage adjustment in the last six months 12 months using the monthly injections and no dose adjustment for the last six months before considering the three-monthly injection APC verdict - present status red. Future status amber with a framework in primary care before transfer (commissioning discussion)
Panitumumab concentrate for infusion	TA439 - Cetuximab and panitumumab for previously untreated metastatic colorectal cancer TA242 - Cetuximab, bevacizumab and panitumumab for the treatment of metastatic colorectal cancer after first-line chemotherapy: Cetuximab (monotherapy or combination chemotherapy), bevacizumab (in combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy	Negative TA
Paracetamol soluble tablets		High sodium content - only if swallowing difficulties.

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
Next page
Last page

University Hospitals Birmingham NHS Foundation Trust

Medicines Formulary

Reports